DIG
OKYO

Dauntless Investment Group’s OKYO Pharma OKYO Stock Holding History

Dauntless Investment Group’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,819
Closed -$6.15K – 93
2026
Q1 		$6.15K Sell
3,819
-467,704
-99% -$908K ﹤0.01% 60
2025
Q4 		$746K Sell
471,523
-1,950,525
-81% -$4.23M 0.59% 27
2025
Q3 		$4.84M Sell
2,422,048
-313,732
-11% -$799K 3.03% 9
2025
Q2 		$1.39M Buy
2,735,780
+747,000
+38% +$1.27M 2.41% 5
2025
Q1 		$2.53M Buy
+1,988,780
New +$2.38M 2.96% 9

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Dauntless Investment Group's OKYO Position: Q2 2026 in Review

Dauntless Investment Group sold out of OKYO Pharma (OKYO) in Q2 2026, closing a stake of 3,819 shares — an estimated $6.15K sold.

Dauntless Investment Group first reported a position in OKYO in Q1 2025 and held it in 5 quarters. The position peaked at $4.84M in Q3 2025. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Dauntless Investment Group reported no remaining OKYO Pharma position as of Q2 2026 after selling out during the quarter.
  • Dauntless Investment Group sold 3,819 OKYO Pharma shares in Q2 2026, an estimated $6.15K.
  • Dauntless Investment Group first reported a position in OKYO Pharma in Q1 2025 and held it in 5 quarters.
  • Dauntless Investment Group's OKYO Pharma position peaked at $4.84M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.